Tijana Radivojevic (left) and Hector Garcia Martin working on mechanical and statistical modeling, data visualizations, and metabolic maps at the Agile BioFoundry last year. (Credit: Thor Swift/Berkeley Lab)
Berkeley Lab scientists develop a tool that could drastically speed up the ability to design new biological systems
If you’ve eaten vegan burgers that taste like meat or used synthetic collagen in your beauty routine – both products that are “grown” in the lab – then you’ve benefited from synthetic biology. It’s a field rife with potential, as it allows scientists to design biological systems to specification, such as engineering a microbe to produce a cancer-fighting agent. Yet conventional methods of bioengineering are slow and laborious, with trial and error being the main approach.
Now scientists at the Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) have developed a new tool that adapts machine learning algorithms to the needs of synthetic biology to guide development systematically. The innovation means scientists will not have to spend years developing a meticulous understanding of each part of a cell and what it does in order to manipulate it; instead, with a limited set of training data, the algorithms are able to predict how changes in a cell’s DNA or biochemistry will affect its behavior, then make recommendations for the next engineering cycle along with probabilistic predictions for attaining the desired goal.
“The possibilities are revolutionary,” said Hector Garcia Martin, a researcher in Berkeley Lab’s Biological Systems and Engineering (BSE) Division who led the research. “Right now, bioengineering is a very slow process. It took 150 person-years to create the anti-malarial drug, artemisinin. If you’re able to create new cells to specification in a couple weeks or months instead of years, you could really revolutionize what you can do with bioengineering.”
Working with BSE data scientist Tijana Radivojevic and an international group of researchers, the team developed and demonstrated a patent-pending algorithm called the Automated Recommendation Tool (ART), described in a pair of papers recently published in the journal Nature Communications. Machine learning allows computers to make predictions after “learning” from substantial amounts of available “training” data.
In “ART: A machine learning Automated Recommendation Tool for synthetic biology,” led by Radivojevic, the researchers presented the algorithm, which is tailored to the particularities of the synthetic biology field: small training data sets, the need to quantify uncertainty, and recursive cycles. The tool’s capabilities were demonstrated with simulated and historical data from previous metabolic engineering projects, such as improving the production of renewable biofuels.
In “Combining mechanistic and machine learning models for predictive engineering and optimization of tryptophan metabolism,” the team used ART to guide the metabolic engineering process to increase the production of tryptophan, an amino acid with various uses, by a species of yeast called Saccharomyces cerevisiae, or baker’s yeast. The project was led by Jie Zhang and Soren Petersen of the Novo Nordisk Foundation Center for Biosustainability at the Technical University of Denmark, in collaboration with scientists at Berkeley Lab and Teselagen, a San Francisco-based startup company.
To conduct the experiment, they selected five genes, each controlled by different gene promoters and other mechanisms within the cell and representing, in total, nearly 8,000 potential combinations of biological pathways. The researchers in Denmark then obtained experimental data on 250 of those pathways, representing just 3% of all possible combinations, and that data were used to train the algorithm. In other words, ART learned what output (amino acid production) is associated with what input (gene expression).
Then, using statistical inference, the tool was able to extrapolate how each of the remaining 7,000-plus combinations would affect tryptophan production. The design it ultimately recommended increased tryptophan production by 106% over the state-of-the-art reference strain and by 17% over the best designs used for training the model.
“This is a clear demonstration that bioengineering led by machine learning is feasible, and disruptive if scalable. We did it for five genes, but we believe it could be done for the full genome,” said Garcia Martin, who is a member of the Agile BioFoundry and also the Director of the Quantitative Metabolic Modeling team at the Joint BioEnergy Institute (JBEI), a DOE Bioenergy Research Center; both supported a portion of this work. “This is just the beginning. With this, we’ve shown that there’s an alternative way of doing metabolic engineering. Algorithms can automatically perform the routine parts of research while you devote your time to the more creative parts of the scientific endeavor: deciding on the important questions, designing the experiments, and consolidating the obtained knowledge.”
More data needed
The researchers say they were surprised by how little data was needed to obtain results. Yet to truly realize synthetic biology’s potential, they say the algorithms will need to be trained with much more data. Garcia Martin describes synthetic biology as being only in its infancy – the equivalent of where the Industrial Revolution was in the 1790s. “It’s only by investing in automation and high-throughput technologies that you’ll be able to leverage the data needed to really revolutionize bioengineering,” he said.
Radivojevic added: “We provided the methodology and a demonstration on a small dataset; potential applications might be revolutionary given access to large amounts of data.”
The unique capabilities of national labs
Besides the dearth of experimental data, Garcia Martin says the other limitation is human capital – or machine learning experts. Given the explosion of data in our world today, many fields and companies are competing for a limited number of experts in machine learning and artificial intelligence.
Garcia Martin notes that knowledge of biology is not an absolute prerequisite, if surrounded by the team environment provided by the national labs. Radivojevic, for example, has a doctorate in applied mathematics and no background in biology. “In two years here, she was able to productively collaborate with our multidisciplinary team of biologists, engineers, and computer scientists and make a difference in the synthetic biology field,” he said. “In the traditional ways of doing metabolic engineering, she would have had to spend five or six years just learning the needed biological knowledge before even starting her own independent experiments.”
“The national labs provide the environment where specialization and standardization can prosper and combine in the large multidisciplinary teams that are their hallmark,” Garcia Martin said.
Synthetic biology has the potential to make significant impacts in almost every sector: food, medicine, agriculture, climate, energy, and materials. The global synthetic biology market is currently estimated at around $4 billion and has been forecast to grow to more than $20 billion by 2025, according to various market reports.
“If we could automate metabolic engineering, we could strive for more audacious goals. We could engineer microbiomes for therapeutic or bioremediation purposes. We could engineer microbiomes in our gut to produce drugs to treat autism, for example, or microbiomes in the environment that convert waste to biofuels,” Garcia Martin said. “The combination of machine learning and CRISPR-based gene editing enables much more efficient convergence to desired specifications.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Biological systems design
- Why The World Needs A 'circular Bioeconomy' - For Jobs, Biodiversity And Prosperityon October 6, 2020 at 8:28 am
Our current economic system, which arguably has succeeded in creating unprecedented economic output, wealth and human welfare over the past 70 years, has led to exacerbated social inequalities and ...
- Tailor-Made Lenses Enable Direct Attachment of High-Tech Microscopes to Cell Incubatorson October 6, 2020 at 7:03 am
An optical device that looks like a tiny lighthouse lens can make it simpler to look closely into Petri dishes and detect molecular-level details of biological systems, such as cancer cell growth.
- CCDC Chemical Biological Center’s Mobile Lab Expertise Enables Readinesson October 6, 2020 at 6:03 am
The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense was tasked with the mission of testing the entire 1st Armored Brigade Combat Team, 34th Infantry Division ...
- Microvi Celebrates Years of Successful Operation of its Commercial MNE Nitrate Treatment System Outperforming Initial Projectionson October 6, 2020 at 6:00 am
Approaching four years of continuous operation, the Microvi MNE system for nitrate removal at Sunny Slope Water Company in Pasadena, CA has outperformed initial projections for performance and cost ...
- CubicFarm Systems Corp. expands market for fresh produce system into insect farming with sale to Agragene Inc.on October 6, 2020 at 5:21 am
CubicFarm® Systems Corp. (TSXV: CUB) ("CubicFarms" or the "Company") is pleased to announce the sale of its automated, controlled-environment system to Agragene Inc. ("Agragene"), a San Diego, ...
Go deeper with Google Headlines on:
Biological systems design
Go deeper with Bing News on:
- Jennifer Doudna’s New Gene Editing Company Launches With A $20 Million Round To Develop Genetic Medicineson October 6, 2020 at 7:14 am
What if you had a tool to change the genetic instructions that cause disease? That's what San Francisco-based Scribe Therapeutics hopes to do with its next-generation platform for gene editing.
- How Machine Learning Made Hops-Free Hoppy Beer (and Other SynBio Wonders) Possibleon October 6, 2020 at 7:00 am
Even with a limited dataset, the AI was able to predict how changes to a cell’s genes can affect its biochemistry and behavior.
- CFN Enterprises Inc. Adds CB Therapeutics to Rapidly Growing Psychedelic Client Rosteron October 6, 2020 at 5:00 am
CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network and agency dedicated to the global legal cannabis, CBD and psychedelics industries, today announced the ...
- Sandia Helps Safeguard Biological Data Threatened During COVID-19 Pandemicon October 6, 2020 at 2:46 am
A partnership between Sandia National Laboratories and the Boston firm BioBright LLC to improve the security of synthetic biology equipment has become more relevant after the United States and others ...
- Synthetic pathways turn plants into biofactories for new moleculeson October 1, 2020 at 7:27 am
Plants can produce a wide range of molecules, many of which help them fight off harmful pests and pathogens. Biologists have harnessed this ability to produce many molecules important for human health ...